Quantbot Technologies’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Quantbot Technologies’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,491	Closed	-$62K	–	1644
2018 Q3	$62K	Buy	+3,491	New	+$59.9K	﹤0.01%	1005
2015 Q3	–	Sell	-390	Closed	-$2K	–	1559
2015 Q2	$2K	Buy	+390	New	+$2.34K	﹤0.01%	1061
2015 Q1	–	Sell	-4,101	Closed	-$25K	–	1494
2014 Q4	$25K	Sell	4,101 -7,005	-63%	-$42.7K	0.01%	934
2014 Q3	$67K	Buy	11,106 +6,401	+136%	+$43.7K	0.01%	936
2014 Q2	$31K	Buy	4,705 +2,905	+161%	+$32.7K	﹤0.01%	999
2014 Q1	$42K	Buy	+1,800	New	+$26.1K	0.01%	834

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Quantbot Technologies's ECYT Position: Q4 2018 in Review

Quantbot Technologies sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 3,491 shares — an estimated $62K sold.

Quantbot Technologies first reported a position in ECYT in Q1 2014 and held it in 6 quarters. The position peaked at $67K in Q3 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Quantbot Technologies reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Quantbot Technologies sold 3,491 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $62K.
Quantbot Technologies first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
Quantbot Technologies's Endocyte, Inc. Common Stock position peaked at $67K in Q3 2014.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Quantbot Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.